Association Between the Phenotype and Genotype of Isoniazid Resistance Among Mycobacterium tuberculosis Isolates in Thailand

Infection and Drug Resistance
Ratchanu CharoenpakChankit Puttilerpong

Abstract

The emergence of isoniazid-resistant tuberculosis (HR-TB) is a global public health problem, causing treatment failure and high mortality rates. This study aimed to determine the minimal inhibitory concentration (MIC) of isoniazid and detect the gene mutation in HR-TB and any association between the level of isoniazid resistance and gene mutation. We collected 74 clinical HR-TB isolates from two tertiary-care centers in Thailand. MICs were established using broth macrodilution. A line probe assay (LPA) was used to detect gene mutations that confer resistance to isoniazid, rifampicin, aminoglycosides, and fluoroquinolones. Sixty-one (82.4%) isolates were monoresistant to isoniazid and 44 (72.1%) were highly resistant to isoniazid. From the clinical isolates, the range of isoniazid MICs was 0.4-16 μg/mL. The katG S315T gene mutation was the prominent mutation in both isoniazid-monoresistant TB (70.5%) and multidrug-resistant TB (72.7%) isolates. The positive predictive value (PPV) of katG was 100% in detecting high levels of isoniazid resistance. The PPV of the inhA mutation was 93.8% in detecting low levels of isoniazid resistance. Five isolates (6.8%) exhibited low-level phenotypic resistance, whereas an LPA failed to detect an...Continue Reading

References

Nov 1, 2013·Global Journal of Health Science·Amornrat AnuwatnonthakateJaranit Kaewkungwal
Nov 5, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Shu-Ting TsengZhi-Yuan Shi
Jun 25, 2015·Microbiology Spectrum·Catherine Vilchèze, William R Jacobs
Jan 26, 2016·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Khin Saw AyeYasuhiko Suzuki
Sep 11, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Ameeruddin Nusrath UnissaNagamiah Selvakumar
Jul 15, 2017·Infection and Drug Resistance·Risara JaksuwanJongkolnee Settakorn
Apr 24, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Galbokka Hewage Roshanthi Eranga KarunaratneJennifer Perera
Apr 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marlanka A ZuurJan-Willem C Alffenaar
Aug 8, 2018·Antimicrobial Agents and Chemotherapy·Justin L KandlerJames E Posey
Feb 13, 2019·The Lancet Infectious Diseases·Kathrin ZürcherUNKNOWN International epidemiology Databases to Evaluate AIDS (IeDEA) consortium

❮ Previous
Next ❯

Software Mentioned

SPSS Statistics
EpiCenter

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.